IMMUNOHEMATOLOGY - LECTINS - ANVISA Registration 10077090141

Access comprehensive regulatory information for IMMUNOHEMATOLOGY - LECTINS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10077090141 and manufactured by manufacturer not specified. The registration is held by FRESENIUS HEMOCARE BRASIL LTDA. with validity until Mar 28, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 3 companies making the same product including FRESENIUS HEMOCARE BRASIL LTDA., LORNE LABORATORIES LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.